跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,926 条关于
“ACR-6840”
全部
5,926
临床试验
4,094
药物
495
机构
75
资讯
1,262
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
7个月前
Acrivon Therapeutics Launches CLIA-Certified Laboratory to Advance Precision Medicine Development
3年前
American College of Rheumatology Launches Initiatives to Reduce Racial Disparities in Lupus Clinical Trials
2年前
Acrivon's ACR-368 Shows Promise in Endometrial Cancer, ACR-2316 Advances to Clinic
2年前
Acrivon Therapeutics' ACR-368 Shows Promise in Endometrial Cancer; ACR-2316 Cleared for Phase 1 Trials
去年
FDA Grants Breakthrough Device Designation to Acrivon's ACR-368 OncoSignature Test for Endometrial Cancer
去年
Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis in New Two-Year Data
去年
2020 ACR Guidelines Challenge Traditional Gout Management in Chronic Kidney Disease Patients
去年
Scilex Presents GLOPERBA® Dosing Data for Gout Patients with Renal Impairment at ACR Convergence
去年
Levicept's LEVI-04 Demonstrates Promising Phase II Results for Knee Osteoarthritis
第 1 页,共 127 页
上一页
下一页